HighTower Advisors
SYNH

HighTower Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

HighTower Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,173
Closed -$256K – 3778
2023
Q1 		$256K Buy
7,173
+1,220
+20% +$44.3K ﹤0.01% 2568
2022
Q4 		$223K Sell
5,953
-3,766
-39% -$149K ﹤0.01% 2692
2022
Q3 		$462K Sell
9,719
-640
-6% -$41.3K ﹤0.01% 2074
2022
Q2 		$744K Sell
10,359
-108
-1% -$7.9K ﹤0.01% 1827
2022
Q1 		$848K Sell
10,467
-739
-7% -$62.5K ﹤0.01% 1856
2021
Q4 		$1.15M Buy
11,206
+119
+1% +$11.4K ﹤0.01% 1698
2021
Q3 		$970K Buy
11,087
+153
+1% +$13.8K ﹤0.01% 1670
2021
Q2 		$974K Buy
10,934
+1,227
+13% +$104K ﹤0.01% 1650
2021
Q1 		$747K Buy
9,707
+620
+7% +$46.7K ﹤0.01% 1740
2020
Q4 		$614K Buy
+9,087
New +$567K ﹤0.01% 1518

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

HighTower Advisors's SYNH Position: Q2 2023 in Review

HighTower Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 7,173 shares — an estimated $256K sold.

HighTower Advisors first reported a position in SYNH in Q4 2020 and held it in 10 quarters. The position peaked at $1.15M in Q4 2021. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • HighTower Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • HighTower Advisors sold 7,173 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $256K.
  • HighTower Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 10 quarters.
  • HighTower Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $1.15M in Q4 2021.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on HighTower Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.